SINOPHARM GROUP CO. LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.55 HKD | +2.04% |
|
+6.37% | +10.27% |
| Jun. 06 | BPH Global to Source Bird's Nest Products from China's Sinopharm; Shares Plummet 40% | MT |
| May. 15 | China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection | MT |
ETFs positioned on Sinopharm Group Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 15 M€ | +15.02% | ||
| 0.00% | 54 M€ | +1.52% | - |
Sinopharm Group Co. Ltd. specialises in the distribution of pharmaceutical products and medical devices to hospitals, clinics, pharmacies and third-party distributors. The group also operates pharmacy chains. Net sales break down by activity as follows:
- distribution of pharmaceutical products (71%) ;
- distribution of medical devices (21.7%);
- operation of directly-owned and franchised pharmacy chains (5.9%);
- other (1.4%).
Sector
Pharmaceuticals
Calendar
2024-06-12
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
20.5
CNY
Average target price
24.68
CNY
Spread / Average Target
+20.40%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.27% | 8.83B | |
| +26.60% | 76.19B | |
| -1.98% | 24.06B | |
| +10.22% | 8.51B | |
| -22.96% | 7.72B | |
| +11.54% | 5.2B | |
| +3.02% | 4.18B | |
| -5.61% | 4.01B | |
| +4.85% | 3.86B | |
| +0.94% | 3.09B |
- Stock Market
- Equities
- 1099 Stock
- Funds and ETFs Sinopharm Group Co. Ltd.
